PALOMBA, STEFANO
 Distribuzione geografica
Continente #
NA - Nord America 1.386
EU - Europa 554
AS - Asia 335
AF - Africa 26
Totale 2.301
Nazione #
US - Stati Uniti d'America 1.367
CN - Cina 307
IT - Italia 153
NL - Olanda 101
SE - Svezia 68
DE - Germania 64
IE - Irlanda 62
FI - Finlandia 51
UA - Ucraina 26
CI - Costa d'Avorio 24
CA - Canada 19
GB - Regno Unito 16
IN - India 14
VN - Vietnam 8
FR - Francia 3
RU - Federazione Russa 3
SG - Singapore 3
BE - Belgio 2
CZ - Repubblica Ceca 2
NG - Nigeria 2
TR - Turchia 2
ES - Italia 1
HK - Hong Kong 1
PL - Polonia 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 2.301
Città #
Chandler 308
Millbury 168
Princeton 114
Nanjing 104
Amsterdam 97
Naples 81
Jacksonville 68
Beijing 63
Wilmington 55
Des Moines 45
Ashburn 41
Nanchang 30
Jiaxing 21
Shenyang 21
Boston 18
Hebei 18
Dublin 16
Changsha 14
Ottawa 14
Tianjin 13
Napoli 12
Seattle 12
Woodbridge 10
Dong Ket 8
Norwalk 8
Washington 6
Boardman 5
Kronberg 5
Yellow Springs 5
Kunming 4
Lanzhou 4
Redwood City 4
Rome 4
Toronto 4
Falls Church 3
Pune 3
Shanghai 3
Singapore 3
Ahmedabad 2
Bagheria 2
Brno 2
Courcelles 2
Enterprise 2
Indiana 2
New York 2
Redmond 2
Saint-Fons 2
Tappahannock 2
Ann Arbor 1
Augusta 1
Bangalore 1
Bratislava 1
Buffalo 1
Cambridge 1
Dearborn 1
Delhi 1
Duncan 1
Fremont 1
Giugliano In Campania 1
Hong Kong 1
Jinan 1
Kolkata 1
Kumar 1
Long Beach 1
Madrid 1
Manduria 1
Markham 1
Ningbo 1
Port Harcourt 1
Regensburg 1
Romano Di Lombardia 1
Rotterdam 1
Salerno 1
Samsun 1
San Diego 1
Simi Valley 1
Springfield 1
Warsaw 1
Zhengzhou 1
Totale 1.463
Nome #
Lack of electrocardiographic changes in women with polycystic ovary syndrome. 61
Cardiopulmonary impairment in young women with polycystic ovary syndrome 49
Overexpression of the phosphoprotein enriched in diabetes gene product (Ped/pea-15) in women with polycystic ovary syndrome. 48
Effects of neridronate treatment in elderly women with osteoporosis 46
Effectiveness of alendronate treatment in postmenopausal women with osteoporosis: Relationship with Bsml vitamin D receptor genotypes 43
Improvement in endothelial structure and function after metformin treatment in young normal-weight women with polycystic ovary syndrome: results of a 6-month study 39
Obesity, type 2 diabetes mellitus and cardiovascular disease risk: an uptodate in the management of polycystic ovary syndrome 39
EFFECTS OF PHYSICAL EXERCISE ON THE FEMALE REPRODUCTIVE SYSTEM. 38
Effects of metformin with or without supplementation with folate on homocysteine levels and vascular endothelium of women with polycystic ovary syndrome. 36
Dose reduction and discontinuation of alendronate in postmenopausal osteoporotic women who were receiving estrogen therapy 34
Metabolic and cardiovascular consequences of polycystic ovary syndrome 34
Lack of an association between peroxisome proliferator-activated receptor-gamma gene Pro12Ala polymorphism and adiponectin levels in the polycystic ovary syndrome 34
Leuprolide acetate treatment with and without coadministration of tibolone in premenopausal women with menstrual cycle-related irritable bowel syndrome. 34
Oral contraceptives versus physical exercise on cardiovascular and metabolic risk factors in women with polycystic ovary syndrome: a randomized controlled trial 34
Adrenal adenoma and normal androgen levels in a young woman with polycystic ovaries: a case of idiopathic hirsutism? 33
Is plasminogen activator inhibitor-1 a cardiovascular risk factor in young women with polycystic ovary syndrome? 33
Cardiovascular complications of obesity in adolescents 32
The increase of leukocytes as a new putative marker of low-grade chronic inflammation and early cardiovascular risk in polycystic ovary syndrome. 31
Evidence for altered adipocyte function in polycystic ovary syndrome 31
Beneficial treatment with risedronate in long-term survivors after allogeneic stem cell transplantation for hematological malignancies 31
Effectiveness of short-term administration of tibolone plus gonadotropin-releasing hormone analogue on the surgical outcome of laparoscopic myomectomy 31
Cardiovascular risk in women with polycystic ovary sydrome 30
BsmI vitamin D receptor genotypes influence the efficacy of antiresorptive treatments in postmenopausal osteoporotic women. A 1-year multicenter, randomized and controlled trial 30
Improvement in endothelial structure and function after metformin treatment in young normal-weight women with polycystic ovary syndrome: Results of a 6-month study 30
Homocysteine levels and C677T polymorphism of methylenetetrahydrofolate reductase in young women with polycystic ovary syndrome. 29
Inflammatory markers and visceral fat are inversely associated with maximal oxygen consumption in women with polycystic ovary syndrome 29
Adiponectin levels in women with polycystic ovary syndrome 29
The cardiovascular risk of young women with polycystic ovary syndrome: an observational, analytical, prospective case-control study 29
Lifestyle changes in the management of adulthood and childhood obesity. 29
Hypothalamic-pituitary-gonadal axis function after successful kidney transplantation in men and women 28
Circulating ghrelin concentrations in the polycystic ovary syndrome 28
Effectiveness of autocrosslinked hyaluronic acid gel after laparoscopic myomectomy in infertile patients: A prospective, randomized, controlled study 28
Insulin sensitivity after metformin suspension in normal-weight women with polycystic ovary syndrome 27
Metabolic and cardiopulmonary effects of detraining after a structured exercise training programme in young PCOS women 26
Effect of estrogen replacement plus low-dose alendronate treatment on bone density in surgically postmenopausal women with osteoporosis 26
Genetic analysis of the follicle stimulating hormone receptor gene in women with polycystic ovary syndrome. 25
Efficacy of risedronate administration in osteoporotic postmenopausal women affected by inflammatory bowel disease 25
Early impairment of endothelial structure and function in young normal-weight women with polycystic ovary syndrome 25
Early carotid atherosclerosis in normotensive severe obese premenopausal women with low DHEA(S). 25
Laparoscopic uterine nerve ablation versus vaginal uterosacral ligament resection in postmenopausal women with intractable midline chronic pelvic pain: A randomized study 25
Endothelial dysfunction in PCOS: role of obesity and adipose hormones 24
A multicenter randomized, controlled study comparing laparoscopic versus minilaparotomic myomectomy: reproductive outcomes 24
Bupivacaine plus epinephrine for laparoscopic myomectomy: A randomized placebo-controlled trial 24
Visceral fat is associated with cardiovascular risk in women with polycystic ovary syndrome 23
Clomiphene citrate versus metformin as first-line approach for the treatment of anovulation in infertile patients with polycystic ovary syndrome 23
Serum aldosterone concentration and cardiovascular risk in women with polycystic ovarian syndrome 22
Leuprolide acetate treatment with and without coadministration of tibolone in premenopausal women with menstrual cycle-related irritable bowel syndrome 22
A prospective randomized comparison between laparoscopic and laparotomic approaches in women with early stage endometrial cancer: A focus on the quality of life 22
Effect of different doses of progestin on uterine leiomyomas in postmenopausal women 22
Ovarian size and blood flow in women with polycystic ovary syndrome and their correlations with endocrine parameters 21
Bone metabolism in postmenopausal women who were treated with a gonadotropin-releasing hormone agonist and tibolone 21
Is plasminogen activator inhibitor-1 a cardiovascular risk factor in young women with polycystic ovary syndrome? 21
Raloxifene administration in women treated with gonadotropin-releasing hormone agonist for uterine leiomyomas: effects on bone metabolism 20
Does raloxifene inhibit the growth of uterine fibroids? [10] (multiple letters) 20
Lack of an association between peroxisome proliferator-activated receptor-γ gene Pro12Ala polymorphism and adiponectin levels in the polycystic ovary syndrome 20
Effect of tibolone on breast symptoms resulting from postmenopausal hormone replacement therapy 20
Gonadal status in reproductive age women after haematopoietic stem cell transplantation for haematological malignancies 19
Polycystic ovary syndrome and obesity: non pharmacological approaches 19
A randomized controlled trial comparing three single-incision minislings for stress urinary incontinence 19
Effects of raloxifene treatment on uterine leiomyomas in postmenopausal women 19
A multicenter randomized, controlled study comparing laparoscopic versus minilaparotomic myomectomy: short-term outcomes 19
Short-term administration of tibolone plus GnRH analog before laparoscopic myomectomy 19
Low 25 (OH) vitamin D levels are associated with autoimmune thyroid disease in polycystic ovary syndrome 18
Are laparoscopic ovarian diathermy and gonadotropin administration the only therapeutic second-steps in clomiphene-citrate resistant women with polycystic ovary syndrome? (multiple letters) [3] 18
Presurgical assessment of intraabdominal visceral fat in obese patients with early-stage endometrial cancer treated with laparoscopic approach: Relationships with early laparotomic conversions 18
Growth hormone secretion after baclofen administration in different phases of the menstrual cycle in healthy women 17
Metformin administration and laparoscopic ovarian drilling improve ovarian response to clomiphene citrate (CC) in oligo-anovulatory CC-resistant women with polycystic ovary syndrome 17
Single-incision Mini-slings Versus Retropubic Tension-free Vaginal Tapes: A Multicenter Clinical Trial 17
Effect of preconceptional metformin on abortion risk in polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials 17
Prospective parallel randomized, double-blind, double-dummy controlled clinical trial comparing clomiphene citrate and metformin as the first-line treatment for ovulation induction in nonobese anovulatory women with polycystic ovary syndrome 16
Uterine effects of metformin administration in anovulatory women with polycystic ovary syndrome 16
Laparoscopic ovarian diathermy vs clomiphene citrate plus metformin as second-line strategy for infertile anovulatory patients with polycystic ovary syndrome: a randomized controlled trial 16
Effectiveness of presacral neurectomy in women with severe dysmenorrhea caused by endometriosis who were treated with laparoscopic conservative surgery: A 1-year prospective randomized double-blind controlled trial 16
Lipid, glucose and homocysteine metabolism in women treated with a GnRH agonist with or without raloxifene 15
Long-term effectiveness and safety of GnRH agonist plus raloxifene administration in women with uterine leiomyomas 15
GH release after GHRH plus arginine administration in obese and overweight women with polycystic ovary syndrome 15
Visceral fat amount as predictive factor for early laparotomic conversion in obese patients with endometrial cancer 15
Effects of metformin with or without supplementation with folate on homocysteine levels and vascular endothelium of women with polycystic ovary syndrome 15
Exon 6 and 2 Peroxisome Proliferator-Activated Receptor-γ Polymorphisms in Polycystic Ovary Syndrome 15
Metformin administration versus laparoscopic ovarian diathermy in clomiphene citrate-resistant women with polycystic ovary syndrome: a prospective parallel randomized double-blind placebo-controlled trial 15
Laparoscopic burch colposuspension: A randomized controlled trial comparing two transperitoneal surgical techniques 15
A randomized controlled trial evaluating metformin pre-treatment and co-administration in non-obese insulin-resistant women with polycystic ovary syndrome treated with controlled ovarian stimulation plus timed intercourse or intrauterine insemination 15
Raloxifene administration in premenopausal women with uterine leiomyomas: a pilot study 14
Relationship between heart rate recovery and inflammatory markers in patients with polycystic ovary syndrome: a cross-sectional study 14
Management strategies for ovulation induction in women with polycystic ovary syndrome and known clomifene citrate resistance 14
Updating of a recent meta-analysis of randomized controlled trials to assess the safety and the efficacy of the laparoscopic surgery for treating early stage endometrial cancer 14
Laparoscopic colposuspension using sutures or prolene meshes: A 3-year follow-up 14
Randomized Controlled Study Comparing the Gynecare Morcellex and Rotocut G1 Tissue Morcellators 14
Long-term Effectiveness of Presacral Neurectomy for the Treatment of Severe Dysmenorrhea Due to Endometriosis 14
Structured exercise training programme versus hypocaloric hyperproteic diet in obese polycystic ovary syndrome patients with anovulatory infertility: a 24-week pilot study 13
Efficacy predictors for metformin and clomiphene citrate treatment in anovulatory infertile patients with polycystic ovary syndrome 13
Lipid profile in nonobese pregnant women with polycystic ovary syndrome: A prospective controlled clinical study 12
Laparoscopic surgery vs laparotomy for early stage endometrial cancer: long-term data of a randomized controlled trial 12
Long-term effectiveness and safety of GnRH agonist plus raloxifene administration in women with uterine leiomyomas 12
Two techniques of laparoscopic retropubic urethropexy 12
Raloxifene administration in premenopausal women with uterine leiomyomas: A pilot study 12
Transdermal hormone replacement therapy in postmenopausal women with uterine leiomyomas 12
Uterine effects of clomiphene citrate in women with polycystic ovary syndrome: a prospective controlled study 11
Laparoscopic treatment for endometrial cancer: A meta-analysis of randomized controlled trials (RCTs) 11
Gonadotropin-releasing hormone agonist with or without raloxifene: Effects on cognition, mood, and quality of life 11
Totale 2.327
Categoria #
all - tutte 10.704
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.704


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201912 0 0 0 0 0 0 0 0 2 0 0 10
2019/2020330 181 2 6 0 8 2 2 0 1 39 41 48
2020/2021112 2 6 14 11 6 34 10 1 9 2 8 9
2021/2022600 5 0 0 4 9 54 2 25 53 57 109 282
2022/2023755 123 57 22 64 88 72 11 57 112 91 48 10
2023/2024336 21 84 110 27 22 26 0 42 4 0 0 0
Totale 2.442